Bayesian Capital Management’s Inogen INGN Stock Holding History

Bayesian Capital Management’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,099	Closed	-$101K	–	707
2025 Q1	$101K	Buy	+14,099	New	+$133K	0.02%	541
2018 Q4	–	Sell	-8,300	Closed	-$2.03M	–	688
2018 Q3	$2.03M	Buy	8,300 +4,800	+137%	+$1.11M	0.33%	72
2018 Q2	$652K	Buy	+3,500	New	+$582K	0.15%	200
2018 Q1	–	Sell	-4,094	Closed	-$488K	–	702
2017 Q4	$488K	Buy	+4,094	New	+$451K	0.1%	317
2017 Q1	–	Sell	-7,033	Closed	-$472K	–	541
2016 Q4	$472K	Buy	+7,033	New	+$434K	0.12%	323
2016 Q2	–	Sell	-5,300	Closed	-$238K	–	469
2016 Q1	$238K	Buy	+5,300	New	+$189K	0.22%	229

Other funds holding INGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bayesian Capital Management's INGN Position: Q2 2025 in Review

Bayesian Capital Management sold out of Inogen (INGN) in Q2 2025, closing a stake of 14,099 shares — an estimated $101K sold.

Bayesian Capital Management first reported a position in INGN in Q1 2016 and held it in 6 quarters. The position peaked at $2.03M in Q3 2018. 127 funds tracked by Wall St. Rank hold INGN as of Q2 2025.

Bayesian Capital Management reported no remaining Inogen position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 14,099 Inogen shares in Q2 2025, an estimated $101K.
Bayesian Capital Management first reported a position in Inogen in Q1 2016 and held it in 6 quarters.
Bayesian Capital Management's Inogen position peaked at $2.03M in Q3 2018.
127 funds tracked by Wall St. Rank held Inogen as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.